Displaying drugs 14301 - 14325 of 15584 in total
Erzotabart
Erzotabart is under investigation in clinical trial NCT04824794 (GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies).
Investigational
Elivaldogene tavalentivec
Investigational
Upinitatug rilsodotin
Upinitatug rilsodotin is under investigation in clinical trial NCT05329545 (Upifitamab Rilsodotin Maintenance in Platinum-sensitive Recurrent Ovarian Cancer (UP-NEXT)).
Investigational
Rivogenlecleucel
Investigational
Bifikafusp alfa
Bifikafusp alfa is under investigation in clinical trial NCT05329792 (L19IL2/L19TNF in Skin Cancer Patients).
Investigational
Bacillus licheniformis
Investigational
Romyelocel-L
Investigational
OBI-833
Investigational
Xanthium sibiricum fruit
Investigational
SYNB1020
SYNB1020 is an engineered strain of Escherichia coli Nissle 1917 developed by Synlogic Inc. It was initially designed to convert ammonia to L-arginine and granted orphan designation by the FDA for the treatment of urea cycle disorders in August 2016; however, the manufacturer discontinued further development of SYNB1020 to treat...
Investigational
Matched Description: … It was initially designed to convert ammonia to L-arginine [A258838] and granted orphan designation by …
4-(2-amino-1,3-thiazol-4-yl)phenol
Experimental
A-620223
Experimental
Sulfabromomethazine
Vet approved
Displaying drugs 14301 - 14325 of 15584 in total